21 Nov, '2022
OAK BROOK, Ill., Nov. 21, 2022 (GLOBE NEWSWIRE) -- In response to numerous inquiries, Sterigenics®, a business of Sotera Health (Nasdaq: SHC), and a global leader in comprehensive sterilization services, today issued the following statement regarding the verdict in favor of the Company in the
02 Nov, '2022
Q3 2022 net revenues of $249 million increased 10% , compared to Q3 2021 Q3 2022 net income of $25 million or $0.09 per diluted share, compared to net income of $27 million or $0.10 per diluted share in Q3 2021 Q3 2022 Adjusted EBITDA of $125 million increased 7% , compared to Q3 2021 Q3 2022
02 Nov, '2022
Global business leader, distinguished general counsel and big law partner to join Sotera Health CLEVELAND, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services
19 Oct, '2022
CLEVELAND, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the
04 Aug, '2022
Q2 2022 net revenues of $267 million increased 6%, compared to Q2 2021 Q2 2022 net income of $30 million or $0.11 per diluted share, compared to net income of $43 million or $0.15 per diluted share in Q2 2021 Q2 2022 Adjusted EBITDA of $136 million increased 1%, compared to Q2 2021 Q2 2022 Adjusted
20 Jul, '2022
Names Michael F. Biehl as Interim Chief Financial Officer
CLEVELAND, July 20, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today
19 May, '2022
CLEVELAND, May 19, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced the departure of Scott Leffler, Sotera Health’s Chief
19 May, '2022
OAK BROOK, Ill., May 19, 2022 (GLOBE NEWSWIRE) -- Sterigenics ® , a business of Sotera Health, and a global leader in comprehensive sterilization services, announced today the beginning of processing at its expanded electron beam (“E-beam”) facility located in Columbia City, Indiana.
05 May, '2022
Q1 2022 net revenues of $237 million increased 12%, compared to Q1 2021 Q1 2022 net income of $31 million or $0.11 per diluted share, compared to net income of $11 million or $0.04 per diluted share in Q1 2021 Q1 2022 Adjusted EBITDA of $115 million increased 10%, compared to Q1 2021 Q1 2022
21 Apr, '2022
CLEVELAND, April 21, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the